To the Editor: In his recent editorial, Talley discusses a range of risks of proton-pump inhibitors (PPIs).1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.